Nitric oxide synthase activity in human trophoblast, term placenta and pregnant myometrium

被引:44
作者
J Al-Hijji
Ellika Andolf
Ricardo Laurini
Satish Batra
机构
[1] Department of Obstetrics/Gynecology, University Hospital
关键词
Nitric Oxide; Cytosolic Fraction; Particulate Fraction; Trophoblastic Cell; Paracrine Effect;
D O I
10.1186/1477-7827-1-51
中图分类号
学科分类号
摘要
To investigate the possible role of nitric oxide (NO) produced locally or intramurally in the quiescence of the pregnant myometrium, nitric oxide synthase (NOS) activity was measured in samples from first trimester (villous, and non villous-trophoblast), term placenta and pregnant myometrium. Trophoblast tissue was obtained from psychosocial termination of pregnancy (9 - 12 weeks' gestation) whereas placenta and myometrium, from the same patient, at deliveries by Caesarean section. NOS activity was measured in both cytosolic and particulate fractions by the formation of 14C-citrulline from 14C-arginine. Western immunoblotting was used to identify the endothelial NOS (eNOS) and neuronal (nNOS) isoforms. The activity of NOS in particulate fractions from all preparations was considerably higher than the cytosolic fractions. Activity in all fractions except the myometrium was highly Ca-dependent. More than 50% of particulate NOS from the myometrium was Ca-independent. NOS activity was highest in the villous trophoblast and there was a significant difference between the villous and non-villous trophoblast. In placenta and myometrium, NOS was 2-4 fold and 20-28-fold lower than the villous trophoblast, respectively. Western blot analysis showed clearly eNOS in the particulate fraction and a weak eNOS band in the cytosolic fractions, whereas nNOS was not detectable in any of the fractions. In view of the marginal activity of NOS in the myometrium, NO produced by the trophoblast and placenta could play a significant role in maintaining uterine quiescence by paracrine effect. © 2003 Al-Hijji et al; licensee BioMed Central Ltd.
引用
收藏
页数:7
相关论文
共 31 条
[1]
Moncada S., Palmer R.M.J., Higgs E.A., Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol. Rev., 43, pp. 109-142, (1991)
[2]
Ignarro L.J., Signal transduction mechanisms involving nitric oxide, Biochem. Pharmacol., 41, pp. 485-490, (1991)
[3]
Sessa V.C., The nitric oxide synthase family of protein, J. Vasc. Res., 31, pp. 131-143, (1994)
[4]
Gude N.M., King R.G., Brennecke S.P., Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta, Lancet, 336, pp. 1589-1590, (1990)
[5]
Gude N.M., Xie C.Y., King R.G., Et al., Effects of eicosanoid and endothelial cell derived relaxing factor inhibition of fetal vascular tone and responsiveness in the human prefused placenta, Trophoblast Res., 7, pp. 133-145, (1993)
[6]
Wieczorek K.M., Brewer A.S., Myatt L., Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature, Am. J. Obstet. Gynecol., 173, pp. 708-713, (1995)
[7]
Conrad K.P., Joffe G.M., Kruszyna H., Et al., Identification of increased nitric oxide biosynthesis during pregnancy in rats, FASEB J., 7, pp. 566-571, (1993)
[8]
Yang D., Lang U., Greenberg S.G., Et al., Elevation of nitrate levels in pregnant ewes and their fetuses, Am. J. Obstet. Gynecol., 174, pp. 573-577, (1996)
[9]
Yllampalli C., Dong Y.-L., Estradiol-17Β in hibits oxide synthase (NOS)-II and stimulates NOS-III gene expression in the rat uterus, Biol. Reprod., 63, pp. 34-41, (2000)
[10]
Natuzzi E.S., Ursell P.C., Harrison M., Buscher C., Riemer R.K., Nitric oxide synthase activity in the pregnant uterus decreases at parturition, Biochem. Biophys. Res. Comm., 194, pp. 1-8, (1993)